Masimo | MASI - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Abbott USD 3.13B 125M 2025-12
Accuray USD 127.32M 500.16M 2025-09
Align Technology USD 441.68M 23.88M 2025-12
AngioDynamics USD 35.99M 14K 2025-02
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
General Electric Aerospace USD 1.58B 385M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Orthofix International USD 130.35M 11.31M 2025-12
Owens Minor USD 462.35M 30.72M 2025-03
ResMed USD 278.4M 19.2M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12